BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31088907)

  • 1. The Codon 72
    Cho JH; Patel B; Bonala S; Mansouri H; Manne S; Vadrevu SK; Ghouse S; Kung CP; Murphy ME; Astrinidis A; Henske EP; Kwiatkowski DJ; Markiewski MM; Karbowniczek M
    Mol Cancer Res; 2019 Aug; 17(8):1639-1651. PubMed ID: 31088907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis.
    Feng Y; Mischler WJ; Gurung AC; Kavanagh TR; Androsov G; Sadow PM; Herbert ZT; Priolo C
    Cancer Res; 2020 Jul; 80(13):2751-2763. PubMed ID: 32393662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch transactivates Rheb to maintain the multipotency of TSC-null cells.
    Cho JH; Patel B; Bonala S; Manne S; Zhou Y; Vadrevu SK; Patel J; Peronaci M; Ghouse S; Henske EP; Roegiers F; Giannikou K; Kwiatkowski DJ; Mansouri H; Markiewski MM; White B; Karbowniczek M
    Nat Commun; 2017 Nov; 8(1):1848. PubMed ID: 29184052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition.
    Barnes EA; Kenerson HL; Jiang X; Yeung RS
    Am J Pathol; 2010 Oct; 177(4):1765-78. PubMed ID: 20813961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
    Gunaratna RT; Santos A; Luo L; Nagi C; Lambertz I; Spier M; Conti CJ; Fuchs-Young RS
    Oncogene; 2019 May; 38(18):3535-3550. PubMed ID: 30651598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study.
    Li S; Zhang Y; Wang Z; Yang Y; Gao W; Li D; Wei J
    Hum Pathol; 2018 Dec; 82():61-67. PubMed ID: 30036593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients.
    Habib SL
    Mol Cancer; 2009 Mar; 8():13. PubMed ID: 19265534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent Eosinophilic Solid and Cystic Renal Cell Carcinoma and Angiomyolipoma With Epithelial Cysts in the Setting of Tuberous Sclerosis Complex: A Rare Synchronous Occurrence of 2 Distinct Entities.
    Cho WC; Collins K; Mnayer L; Cartun RW; Earle JS
    Int J Surg Pathol; 2019 Oct; 27(7):804-811. PubMed ID: 31142207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
    Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
    Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.
    Guo Y; Dreier JR; Cao J; Du H; Granter SR; Kwiatkowski DJ
    PLoS One; 2016; 11(12):e0167384. PubMed ID: 27907099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: an autopsy case report with p53 gene mutation analysis.
    Sato K; Ueda Y; Tachibana H; Miyazawa K; Chikazawa I; Kaji S; Nojima T; Katsuda S
    Pathol Res Pract; 2008; 204(10):771-7. PubMed ID: 18547741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.
    Kung CP; Liu Q; Murphy ME
    Cancer Biol Ther; 2017 Jul; 18(7):484-491. PubMed ID: 28475405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.
    Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN
    Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond.
    Henske EP
    Pediatr Nephrol; 2005 Jul; 20(7):854-7. PubMed ID: 15856327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEComas: the past, the present and the future.
    Martignoni G; Pea M; Reghellin D; Zamboni G; Bonetti F
    Virchows Arch; 2008 Feb; 452(2):119-32. PubMed ID: 18080139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models.
    Zhao Y; Wu L; Yue X; Zhang C; Wang J; Li J; Sun X; Zhu Y; Feng Z; Hu W
    Elife; 2018 Mar; 7():. PubMed ID: 29557783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex: tumors and tumorigenesis.
    Borkowska J; Schwartz RA; Kotulska K; Jozwiak S
    Int J Dermatol; 2011 Jan; 50(1):13-20. PubMed ID: 21182496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.